Skip to main content

Table 2 Prevalence and co-occurrence of urogenital species among 28 Trichomonas vaginalis-positive and 51 T. vaginalis-negative women

From: Urogenital pathogens, associated with Trichomonas vaginalis, among pregnant women in Kilifi, Kenya: a nested case-control study

Species Overall prevalence (N = 79) (95% CI) %TV+/%TV- Univariate analysis Multivariate analysis
COR
(95% CI)
P-value AOR
(95% CI)
P-value
Candida albicans 24.1 (15.1–35.0) 32.1/19.6 1.9 (0.7–5.6) 0.216
Chlamydia trachomatis 13.9 (7.2–23.5) 21.4/9.8 2.5 (0.7–9.1) 0.163
Escherichia coli 27.8 (18.3–39.1) 35.7/23.5 1.8 (0.7–4.9) 0.251
Mycoplasma genitalium 6.3(2.1–14.2) 17.9/0.0 5.0 (0.3–94.3)* 0.002   
Ca. Mycoplasma girerdii 7.6 (2.8–15.8) 21.4/0.0 4.3 (0.2–78.4)* 0.001   
Mycoplasma hominis 41.8 (30.8–53.4) 71.4/25.5 7.3 (2.6–20.5) <  0.001 6.8 (2.3–19.8) <  0.001
Streptococcus agalactiae 11.4 (5.3–20.5) 7.1/13.7 0.5 (0.1–2.5) 0.386
Ureaplasma parvum 74.7 (63.6–83.8) 78.9/72.6 1.4 (0.5–4.1) 0.557
Ureaplasma urealyticum 48.1 (36.7–59.6) 60.7/41.2 2.2 (0.9–5.7) 0.099 1.3 (0.4–3.8) 0.624
Cytomegalovirus 1.3 (0–6.9) 0.0/2.0 1.7 (6.6–4210.4)* 0.456   
HIV 3.8 (0.7–10.7) 10.7/0.0 7.9 (0.4–158.5)* 0.017   
HSV 1, HSV 2 2.5 (0.3–8.8) 7.1/0.0 11.1 (0.5–238.6)* 0.053   
Bacterial vaginosis 5.1 (1.4–12.5) 14.3/0.0 6.2 (0.3–118.4)* 0.006   
  1. TV Trichomonas vaginalis, HIV human immunodeficiency virus, HSV1 herpes simplex virus type 1; herpes simplex virus type 2, COR crude odds ratio, AOR adjusted odds ratio
  2. in bold: significantly associated, i.e., P ≤ 0.05* Separate computation not included in multivariable model